Celea Therapeutics

Celea Therapeutics develops drug therapies for serious respiratory and fibrotic lung diseases.

Health and bio

Latest funding

$180M Series A · July 2, 2026

Source: fundraisingfox.com

Funding history ↓

Website: celeatx.com.

X: @CeleaTx · 10 followers.

LinkedIn: celea-therapeutics.

Category: Health and bio.

Sectors: Biopharma, Biotechnology, Clinical Trials, Health Care, Medical.

Stage: Series A.

Based in: Boston, United States.

Last round: Jul 2, 2026 · 136 days ago.

Headcount: 11–50 employees.

On Recent Funding since: Sep 29, 2026.

Signals

X account@CeleaTx · created Aug 1, 2025 (15 months old) · 10 followers

Website registeredAug 8, 2025 (15 months old)

About Celea Therapeutics

The company focuses on idiopathic pulmonary fibrosis (IPF) and is advancing deupirfenidone, an oral investigational therapy. Its customers are patients and physicians.

TIMELINE · MONEY RAISED

Celea Therapeutics | 335 days from X account to first raise on record

@CeleaTx·Raised $180M in 1 sourced round·2 signals before the first raise

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Funding rounds

Date	Round	Amount	Lead	Source
Jul 2, 2026	Series A	$180M	—	fundraisingfox.com

Timeline

August 8, 2025
Website created
August 1, 2025
X account created

Investors

Companies like Celea Therapeutics

SStar Therapeutics$200M Series B+ · Oct 2026
GGranite Bio$30M Series A · Apr 2025
HHotSpot Therapeutics$100M Series B+ · Nov 2021
AAirNexis Therapeutics$200M Series A · Jan 2026
MMirador Therapeutics$250M Series B+ · Jan 2026
RRevagenixSeries B+ · Jan 2024

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/celea-therapeutics (get a free API key).